Intuitive Surgical (NASDAQ:ISRG) Shares Gap Down After Analyst Downgrade

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) gapped down before the market opened on Wednesday after Royal Bank Of Canada lowered their price target on the stock from $575.00 to $550.00. The stock had previously closed at $438.00, but opened at $402.50. Royal Bank Of Canada currently has an outperform rating on the stock. Intuitive Surgical shares last traded at $417.6190, with a volume of 1,142,782 shares trading hands.

Several other analysts have also recently issued reports on ISRG. Sanford C. Bernstein restated an “outperform” rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Oppenheimer reaffirmed an “outperform” rating and issued a $500.00 price target on shares of Intuitive Surgical in a report on Wednesday. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Sunday, September 20th. BTIG Research reissued a “buy” rating and set a $454.00 price objective on shares of Intuitive Surgical in a research note on Wednesday. Finally, Barclays reissued an “overweight” rating and set a $500.00 price objective (up from $485.00) on shares of Intuitive Surgical in a research note on Wednesday. Twenty-five equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $497.39.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amy Ladd sold 400 shares of the company’s stock in a transaction on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the transaction, the director owned 251 shares of the company’s stock, valued at $95,129. This represents a 61.44% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Guthart sold 10,000 shares of the stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total value of $4,000,000.00. Following the completion of the sale, the director owned 1,245,679 shares in the company, valued at approximately $498,271,600. The trade was a 0.80% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 12,370 shares of company stock worth $4,891,989 over the last quarter. 0.60% of the stock is owned by insiders.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical reported third-quarter revenue of $3.05 billion, up 21.7% year over year and above the approximately $2.91 billion analyst estimate. Adjusted earnings of $3.00 per share also exceeded consensus, while worldwide procedures increased about 15% and da Vinci system placements rose to 546 from 427 a year earlier. Intuitive Surgical Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Several analysts remain constructive: Bernstein reaffirmed a Buy rating with a $685 price target, BTIG maintained Buy, Baird raised its target to $550, and Erste Group upgraded the stock to Buy. These actions reflect confidence in robotic-surgery demand, the da Vinci platform and Intuitive’s innovation pipeline. Analyst Ratings and Price Target
• Neutral Sentiment: RBC Capital retained its Outperform rating while lowering its target to $550 from $575. Raymond James also trimmed its target to $480 from $483, while Mizuho cut its target to $400 and kept a Neutral rating, creating a mixed analyst picture. RBC Capital Price Target Update
• Negative Sentiment: GAAP profit fell to $1.49 per share because Intuitive recorded a $450 million pretax charge, or approximately $0.99 per share after tax, tied to a proposed antitrust settlement. The settlement still requires court approval, adding legal and earnings uncertainty. Antitrust Settlement Charge
• Negative Sentiment: Management narrowed its 2026 global da Vinci procedure-growth forecast to 14%-15%. Planned actions to reduce per-procedure instrument costs by roughly 3%-5% may support long-term adoption but could pressure near-term revenue and margins. Reports also highlighted a slowdown in U.S. procedure growth, which amplified the market’s reaction. Intuitive Narrows Procedure Growth Outlook

Hedge Funds Weigh In On Intuitive Surgical

A number of institutional investors have recently modified their holdings of ISRG. Sowell Financial Services LLC grew its holdings in Intuitive Surgical by 6.0% during the 3rd quarter. Sowell Financial Services LLC now owns 4,497 shares of the medical equipment provider’s stock worth $1,829,000 after acquiring an additional 253 shares in the last quarter. Quadrant Capital Group LLC increased its position in shares of Intuitive Surgical by 50.4% during the third quarter. Quadrant Capital Group LLC now owns 13,267 shares of the medical equipment provider’s stock worth $5,599,000 after purchasing an additional 4,448 shares in the last quarter. Physician Wealth Advisors Inc. lifted its holdings in shares of Intuitive Surgical by 136.9% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 154 shares of the medical equipment provider’s stock valued at $63,000 after purchasing an additional 89 shares during the last quarter. Pinnacle Associates Ltd. lifted its holdings in shares of Intuitive Surgical by 37.4% during the 3rd quarter. Pinnacle Associates Ltd. now owns 3,878 shares of the medical equipment provider’s stock valued at $1,577,000 after purchasing an additional 1,056 shares during the last quarter. Finally, Harfst & Associates Inc. boosted its position in shares of Intuitive Surgical by 5.2% in the 3rd quarter. Harfst & Associates Inc. now owns 4,290 shares of the medical equipment provider’s stock worth $1,744,000 after purchasing an additional 212 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Down 2.7%

The stock has a 50-day moving average price of $392.96 and a two-hundred day moving average price of $409.06. The stock has a market cap of $150.55 billion, a price-to-earnings ratio of 48.45, a PEG ratio of 3.27 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%. The company had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. During the same period in the prior year, the company posted $2.40 EPS. The firm’s quarterly revenue was up 21.7% compared to the same quarter last year. Research analysts predict that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.